Sakshi Education
Indian Institute of Technology Madras (IIT-M) on 20 December, 2019 announced that it is going to collaborate with Ricovr Inc. -- US-based oral diagnostics medical device company, for research on point-of-care medical device development.
Point-of-care diagnostics, or near-patient testing, is a type of medical diagnostic test that enables accurate, real-time, laboratory-quality diagnostic test results within minutes.
Testing at the point of care in this way increases the efficiency of diagnostic and testing process, and helps to ensure that patients are receiving the highest-quality care by freeing up invaluable time normally occupied by waiting for test results.
V. V. Raghavendra Sai, Associate Professor, Biomedical Engineering, Department of Applied Mechanics, IIT Madras added that IIT Madras researchers have discovered a highly sensitive optical sensing phenomenon and developed a plasmonic nanomaterial based sensing platform that can aid in affordable and more efficient diagnostics.
Point-of-care diagnostics market that the company operates in is expected to generate US $50.51 billion in revenues by 2026 in the US alone.
Ricovr is currently working on building a cutting-edge medical device for point-of-care testing using saliva.
This strategic partnership will bolster cutting-edge research and development by bringing together some of the most talented and experienced professionals in the biosensor industry.
Source: IANS
Testing at the point of care in this way increases the efficiency of diagnostic and testing process, and helps to ensure that patients are receiving the highest-quality care by freeing up invaluable time normally occupied by waiting for test results.
V. V. Raghavendra Sai, Associate Professor, Biomedical Engineering, Department of Applied Mechanics, IIT Madras added that IIT Madras researchers have discovered a highly sensitive optical sensing phenomenon and developed a plasmonic nanomaterial based sensing platform that can aid in affordable and more efficient diagnostics.
Point-of-care diagnostics market that the company operates in is expected to generate US $50.51 billion in revenues by 2026 in the US alone.
Ricovr is currently working on building a cutting-edge medical device for point-of-care testing using saliva.
This strategic partnership will bolster cutting-edge research and development by bringing together some of the most talented and experienced professionals in the biosensor industry.
Source: IANS
Published date : 21 Dec 2019 01:38PM
More Articles
